US Edition
News from Cambridge Times
Top Cambridge Times News
Alzheimer's Disease · United StatesSelf-testing and self-treating are becoming bigger trends in medicine, and now, you can conduct part of your treatment at home by yourself if you have Alzheimer’s disease. On Aug. 30, the U.S. Food and Drug Administration (FDA) approved the first at-home treatment for Alzheimer’s. Lecanemab, sold under the brand name Leqembi—which the FDA approved in 2023 as the first medication to treat the memory disorder—is now available in a self-injecting p…See the Story
You Can Now Inject Yourself With an Alzheimer’s Drug at Home
53% Center coverage: 32 sources
